HOTH•benzinga•
Hoth Therapeutics Announces Initial Data In CLEER-001 Phase 2a Clinical Trial Of HT-001; Says Patients Experienced A 50% Reduction In Pruritus Severity, With Mean Scores Dropping From 1.6 On Day 1 To 0.8 By Day 21
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 15, 2025 by benzinga